Other members of the high-level advisory committee are former RBI Deputy Governor Usha Thorat, former Securities and Exchange Board of India Chairman C B Bhave, and Nachiket M Mor, Director of the Central Board of Directors of RBI, Governor Raghuram Rajan said.
Sundararaman Ramamurthy has been an interesting choice for the publicly-listed BSE, which has seen its chief move to bigger rival -- the National Stock Exchange (NSE) -- in July. Having spent nearly two decades at the country's largest bourse, Ramamurthy is among the early architects of NSE and understands all the cogs of the exchange wheel like only a few others in the country. Just like NSE's core team, which includes its founder RH Patil, the 59-year-old Ramamurthy has worked at the Industrial Development Bank of India (IDBI) before moving to NSE in 1995.
In the context of market integrity, the IRAI and RBI should go over the minutes of the LIC and SBI board meetings when the decisions to invest in Adani equity or debt were taken, notes Jaimini Bhagwati, former World Bank treasury professional.
India on Thursday said it keeps a constant watch on all developments having bearing on national security, three days after new satellite images indicated the construction of a Chinese village east of the Doklam plateau on the Bhutanese side.
It said alongside the village is a neatly marked all-weather carriageway, which is part of China's "extensive land grab" in Bhutan.
The Serum Institute of India is the first Indian company to seek approval for the COVID-19 booster dose.
But it would be unwise on the government's part not to heed the suggestions made by the experts group, set up by the Supreme Court, in particular the one on involving the states and giving them the flexibility in designing and implementing the farm laws, observes A K Bhattacharya.
There was a huge uproar in the Commonwealth Games gold medal match after Australia cricketer Tahlia McGrath was allowed to play the T20 final against India on Sunday despite testing positive for COVID-19.
The WADA first suspended NDTL in August 2019 for six months and extended the de-recognition period after its inspections showed that non-conformities still existed.
The decision comes after the game's rule-making body IFAB last month gave the go-ahead for trials of additional 'concussion subs'.
The Centre's interlocutor and retired IPS officer RN Ravi has been shifted from Nagaland to Tamil Nadu as its new governor.
This doctor couple put their faith in India. And in return India has put faith in them.
The Centre has also contacted five domestic and three multinational vaccine makers to understand how soon a candidate vaccine against Covid-19 will be ready.
The procurement and distribution will be centralised though the government is yet to take a call on the initial number of doses that will be procured.
NITI Aayog's attempt to bust coronavirus myths provokes a virtual storm of controversy.
Bhutan on Thursday announced that it firmed up a "three-step roadmap" for expediting the negotiations with China to resolve the long-pending boundary dispute between the two countries, a development that India said it has taken note of.
The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech's EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.
Lack of skilled labour, among other factors, led to 187,062 vacancies in nine sectors during the first quarter of the current fiscal year, showed the new revamped quarterly employment survey (QES). This accounted for a little over 0.6 per cent of the total jobs given by these establishments till April-June 2021-22. The nine sectors - manufacturing, construction, trade, transport, education, health, accommodation and restaurants, IT/BPOs and financial services - employed 30.8 million people.
The first 100 beneficiaries of such foreign vaccines shall be assessed for seven days for safety outcomes before it is rolled out for further immunisation programme within the country, the Union health ministry said.
The Centre wrote to all states and union territories on Thursday and asked them to make necessary arrangements for this, the Union Health Ministry said.
The UK's medicines regulator on Thursday approved a new antibody treatment against COVID-19, which it believes will also be effective against new variants such as Omicron.
In the trial, the vaccine will be given by the intramuscular route in two doses on day 0 and day 28.
The panel also recommended giving approval to Bharat Biotech for carrying out a study on interchangeability of its Covaxin and the under-trial adenoviral intranasal vaccine candidate BBV154, but asked the Hyderabad-based firm to remove the word "interchangeability" from the study title and submit a revised protocol for approval.
According to officials, an additional dose of vaccine is different from a booster dose.
The Kerala government has told the Supreme Court that it is "vigorously vaccinating" people against Covid-19 and is expected to inoculate at least 60 per cent of its population within two or three months.
The COVID-19 vaccine of Biological-E is currently undergoing phase-3 clinical trial after showing promising results in phase 1 and 2 trials.
If the vaccine is recommended for use as a booster against Omicron, it may significantly boost the demand for Covishield in India.
Not enough data has been generated locally to decide on the need for a booster dose of COVID-19 vaccine for those fully inoculated, say experts amid the possibility of a third wave of the viral disease hitting the country between September and October.
In a statement, the PMO said three vaccines are in advanced stages of development in India, out of which two are in Phase II and one is in Phase-III. It further said Indian Scientists and research teams are collaborating and strengthening the research capacities in neighbouring countries such as Afghanistan, Bhutan, Bangladesh, Maldives, Mauritius, Nepal and Sri Lanka.
The Kerala high court has directed the Centre to allow scheduling, on CoWIN portal, of second Covishield dose after four weeks from the first for those who want to take it earlier than the present suggested gap of 84 days.
A bench headed by Chief Justice NV Ramana took note of a report filed by the commission which informed it that a decision to lift the ban on certain industries has been taken.
The WHO's move came nearly three weeks after India objected to the B.1.617 mutant of the novel coronavirus being termed an 'Indian Variant' in media reports with the Union Health Ministry pointing out that the UN's top health organ has not used the word 'Indian' for this strain in its document.
India achieved this coverage in 130 days as against the USA's feat in 124 days.
The decision was taken after a meeting of the Max Healtcare authorities in connection with the incident.
Under the new guidelines, the top 10 active equity schemes in terms of assets would collectively require investments of around Rs 365 crore -- up from mandated Rs 50 lakh at present -- in their own schemes.
Asked if the government has decided to administer the COVID-19 vaccine to the entire population free of cost on priority basis and if so, the target fixed to administer the doses, the health minister said according to Revised Guidelines for Implementation of National COVID Vaccination Program, which came into effect from June 21, all citizens aged 18 years and above, irrespective of their income status, are entitled to free vaccination at all government vaccination centres.
Stressing on the need to protect both lives and livelihoods, he said public health action in India and across the world must be continually guided by evidence from four key questions -- how transmissible is the variant, severity of the disease it causes, how well vaccines and prior SARS-CoV-2 infection protect and how common people perceive risk and follow control measures.
The Centre told the Bombay high court on Tuesday that a door-to-door COVID-19 vaccination programme for senior citizens, specially-abled, bed-ridden and wheelchair-bound people is currently not possible, but it has decided to start 'near-to-door' inoculation centres.
'Better to prevent than to wait for evidence. Protection delayed can also mean protection denied'
The decision empowers pregnant women to make an informed choice on taking the Covid vaccination, the ministry said, adding these women can now register on CoWIN or walk-in to the nearest Covid vaccination centre to get themselves inoculated.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances